Home › Left Ventricular Dysfunction › Missouri › St. Louis
Left Ventricular Dysfunction clinical trials in St. Louis, MO
3 studies for Left Ventricular Dysfunction are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
RecruitingPhase 2/3
- Washington University-Pediatric Cardiology/ St. Louis Children's Hospital ( Site 0006), St Louis
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
Left Ventricular Dysfunction trials in other cities
- Cleveland, OH4 studies
- New York City, NY4 studies
- Philadelphia, PA3 studies
- Ann Arbor, MI3 studies
- Aurora, CO3 studies
- Atlanta, GA3 studies
- Cincinnati, OH3 studies
- Boston, MA3 studies
- Pittsburgh, PA3 studies
- Houston, TX3 studies
- The Bronx, NY3 studies
- Dallas, TX3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer71 studies
- Breast Cancer64 studies
- Metastatic Cancer53 studies
- Colorectal Cancer49 studies
- Prostate Cancer47 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer37 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.